These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10645028)

  • 61. Commentary on: intimal hyperplasia: slow but deadly.
    Perfusion; 2012 Nov; 27(6):529. PubMed ID: 23118127
    [No Abstract]   [Full Text] [Related]  

  • 62. Gene therapy for arterial disease.
    Isner JM; Feldman LJ
    Lancet; 1994 Dec; 344(8938):1653-4. PubMed ID: 7996957
    [No Abstract]   [Full Text] [Related]  

  • 63. Gene Therapy Update.
    Pereira EM
    Pediatr Rev; 2022 Sep; 43(9):536-537. PubMed ID: 36045154
    [No Abstract]   [Full Text] [Related]  

  • 64. Potent inhibition of arterial intimal hyperplasia by TIMP1 gene transfer using AAV vectors.
    Ramirez Correa GA; Zacchigna S; Arsic N; Zentilin L; Salvi A; Sinagra G; Giacca M
    Mol Ther; 2004 Jun; 9(6):876-84. PubMed ID: 15194054
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Local administration of NF-kappa B decoy oligonucleotides to prevent restenosis after balloon angioplasty: an experimental study in New Zealand white rabbits.
    Kalinowski M; Viehofer K; Hamann C; Barry JJ; Kleb B; Klose KJ; Wagner HJ; Alfke H
    Cardiovasc Intervent Radiol; 2005; 28(3):331-7. PubMed ID: 15886949
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Characterization of a new double-injury restenosis model in the rat aorta.
    Jahnke T; Karbe U; Schäfer FK; Bolte H; Heuer G; Rector L; Brossmann J; Heller M; Müller-Hülsbeck S
    J Endovasc Ther; 2005 Jun; 12(3):318-31. PubMed ID: 15943507
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Update on gene therapy for intimal hyperplasia.
    Reis ED; Skladany M
    Bratisl Lek Listy; 1999 Aug; 100(8):417-21. PubMed ID: 10645028
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Treatment of intimal hyperplasia by gene therapy: an update].
    Reis E; Martinet O; Mosimann F
    J Mal Vasc; 1999 Dec; 24(5):349-55. PubMed ID: 10642646
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Fas ligand gene therapy for vascular intimal hyperplasia.
    Jiang C; Yang YF; Cheng SH
    Curr Gene Ther; 2004 Mar; 4(1):33-9. PubMed ID: 15032612
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Gene therapy of fibroproliferative vasculopathies: current ideas in molecular mechanisms and biomedical technology.
    Mitra AK; Agrawal DK
    Pharmacogenomics; 2006 Dec; 7(8):1185-98. PubMed ID: 17184206
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Hyperplasia of the arterial intima due to smooth muscle cell proliferation. Current data, experimental treatments and perspectives].
    Ducasse E; Cosset JM; Eschwège F; Chevalier J; De Ravignan D; Puppinck P; Lartigau E
    J Mal Vasc; 2003 Jun; 28(3):130-44. PubMed ID: 12910189
    [TBL] [Abstract][Full Text] [Related]  

  • 72.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.